Inhibition of cell cycle progression on HepG2 cells by hypsiziprenol A 9, isolated from Hypsizigus marmoreus

Cancer Letters

Volumn 212, Issue 1, 2004, Pages 7-14

  Chang, Jong Sun ^a   Son, Jong Keun ^a   Li, Gao ^a   Oh, Eun Jung ^a   Kim, Ji Young ^a   Park, Sun Hee ^a   Bae, Joon Tae ^b   Kim, Hyun Jeong ^c   Lee, In Seon ^c   Kim, Ok Mi ^d   Kozukue, Nobuyuki ^a   Han, Jae Sook ^a   Hirose, Masao ^e   Lee, Kap Rang ^a  

^a Yeungnam University   (South Korea)

^b Asia University   (South Korea)

^c Keimyung University   (South Korea)

^d Department of Hotel Cooker   (South Korea)

^e NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Cell cycle arrest; Cyclin D1; Cyclin E; Hypsizigus marmoreus; Hypsiziprenol A9; Retinoblastoma protein

Indexed keywords

CYCLIN D1; CYCLIN E; HYPSIZIGUS MARMOREUS EXTRACT; HYPSIZIPRENOL A 9; METHANOL; PLANT EXTRACT; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPSIZIGUS MARMOREUS; IN VITRO STUDY; INHIBITION KINETICS; MUSHROOM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TIME;

AGARICALES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CYCLIN D1; CYCLIN E; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ALCOHOLS; HUMANS; LIVER NEOPLASMS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

BASIDIOMYCOTA;

EID: 3042771858     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.013     Document Type: Article

References (38)

1. Kodama N., Komuta K., Nanba H. Can maitake MD-fraction aid cancer patients? Altern. Med. Rev. 7:2002;236-239
2. Kabir Y., Hoshino T., Komai M., Kimura S. Histopathological changes in spontaneously hypertensive rats after feeding shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushroom diets. J. Clin. Biochem. Nutr. 6:1989;187-193
3. Borchers A.T., Stern J.S., Hackman R.M. Mushrooms, tumors, and immunity. Proc. Soc. Exp. Biol. Med. 221:1999;281-293
4. Mizuno T. Development of antitumor polysaccharides from mushroom fungi. Food Food Ingred. J. Jpn. 167:1996;69-85
5. Mizuno T. The extraction and development of antitumor active polysaccharides from medicinal mushrooms in Japan. Int. J. Med. Mushrooms. 1:1999;9-29
6. Wasser S.P., Weis A.L. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives. Int. J. Med. Mushrooms. 1:1999;31-62
7. Mohacek-Grosev V., Bozac R., Puppels G.J. Vibrational spectroscopic characterization of wild growing mushrooms and toadstools. Spectrochim. Acta A Mol. Biomol. Spectrosc. 57:(14):2001;2815-2829
8. Matsuzawa T., Saitoh H., Sano M., Tomita I., Ohkawa M., Ikekawa T. Studies on antioxidant effects of Hypsizigus marmoreus. Effects of Hypsizigus marmoreus for antioxidant activities of tumor-bearing mice. Yakugaku Zasshi. 118:1998;476-482
9. Sherr C.J. The Pezcoller lecture. Cancer cell cycles revisited. Cancer Res. 60:2000;3689-3695
10. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature. 411:2001;342-348
11. Nevins J.R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10:2001;699-703
12. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazoliium/formazan assay for cell growth assays in culture. Cancer Commun. 3:1991;207-212
13. Vindelov L.L., Christensen I.J., Nissen N.I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 3:1983;323-327
14. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-252
15. Sawabe A., Morita M., Ouchi S., Okamoto T. Fast atom bombardment mass spectrometry and linked scan analyses at constant B/E in the structural characterization of new polyisoprenepolyols isolated from an edible mushroom (Hypsizigus marmoreus). J. Mass Spectrom. 31:1996;921-925
16. Sawabe A., Morita M., Kiso T., Kishine H., Ohtsubo Y., Ouchi S., et al. Structural analyses of a precursory substance of bitterness: new polyisoprenepolyols isolated from an edible mushroom (Hypsizigus marmoreus) by fast atom bombardment mass spectrometry. J. Agric. Food Chem. 47:1999;588-593
17. Miller A.B. Diet and cancer: a review. Rev. Oncol. 3:1990;87-95
18. Hong W.K., Sporn M.B. Recent advances in chemoprevention of cancer. Science. 278:1997;1073-1077
19. Sporn M.B. Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res. 51:1991;6215-6218
20. Chang R. Functional properties of edible mushrooms. Nutr. Rev. 54:1996;91-93
21. Mizuno M., Shiomi Y., Minato K., Kawakami S., Ashida H., Tsuchida H. Fucogalactan isolated from Sarcodon aspratus elicits release of tumor necrosis factor-alpha and nitric oxide from murine macrophages. Immunopharmacology. 46:(2):2000;113-121
22. Yuan Z., He P., Takeuchi H. Ameliorating effects of water-soluble polysaccharides from woody ear (Auricularia auricula-judae Quel.) in genetically diabetic KK-Ay mice. J. Nutr. Sci. Vitaminol. 44:(6):1998;829-840
23. Liu Y.H., Kao M.C., Lai Y.L., Tsai J.J. Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: using Dp2 peptide and fungal immunomodulatory peptide. J. Allergy Clin. Immunol. 112:(2):2003;301-310
24. Lee E.W., Shizuki K., Hosokawa S., Suzuki M., Suganuma H., Inakuma T., et al. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci. Biotechnol. Biochem. 64:(11):2000;2402-2405
25. Ikekawa T., Saitoh H., Feng W.J., Zhang H.L., Li L.F., Matsuzawa T. Antitumor activity of Hypsizigus marmoreus. I. Antitumor activity of extracts and polysaccharides. Chem. Pharm. Bull. 40:1992;1954-1957
26. Saitoh H., Feng W.J., Matsuzawa T., Ikekawa T. Antitumor activity of Hypsizigus marmoreus. Preventive effect against lung metastasis of Lewis lung carcinoma. Yakugaku Zasshi. 117:1997;1006-1010
27. Tsuchida K., Aoyagi Y., Odani S., Mita T., Isemura M. Isolation of a novel collagen binding protein from the mushroom, Hypsizigus marmoreus, which inhibits the lewis lung carcinoma cell adhesion to type IV collagen. J. Biol. Chem. 270:1995;1481-1484
28. Shoji Y., Isemura M.I., Muto H., Isemura S., Aoyagi Y. Isolation of a 41-kDa protein with cell adhesion activity for animal tumor cells from the mushroom, Hypsizigus marmoreus by affinity chromatography with Type IV collagen immobilized on agarose. Biosci. Biotechnol. Biochem. 64:2000;775-780
29. Nozoe S. Study on search for physiologically active substances. Farumashia. 27:1991;543-546
30. Nozoe S. Medicinally active substances in mushroom. Takemaru. Mushroom Fundamental Science and New Technology. 1991;136-144 Nosonbunkasya, Japan
31. Ohtsubo M., Roberts J.M. Cycin dependent regulation of G1 in mammalian cells. Science. 259:1993;1908-1915
32. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163
33. Hiroyuki O. Bioprobes for investigating mammalian cell cycle control. J. Antibiot. 51:1998;11-15
34. Bernards R. E2F: a nodal point in cell cycle regulation. Biochim. Biophys. Acta. 1333:1997;M33-M40
35. Allan A.L., Albanese C., Pestell R.C., LaMarre J. Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. J. Biol. Chem. 276:(29):2001;27272-27280
36. Alisi A., Leoni S., Piacentani A., Conti Devirgiliis L. Retinoic acid modulates the cell-cycle in fetal rat hepatocytes and HepG2 cells by regulating cyclin-cdk activities. Liver. 23:2003;79-86
37. Suzui M., Masuda M., Lim J.T., Albanese C., Pestell R.G., Weinstein I.B. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21 (IP1) and inhibition of expression of cyclin D1. Cancer Res. 62:(14):2002;3997-4006
38. Wang J., Hsieh Y.J., Chu C.Y., Lin Y.L., Tseug T.H. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 183:2002;163-168